What is Australia’s potential new COVID treatment? Half a million doses of the oral antiviral candidate could become available from next year, pending TGA approval.
GPs could soon have an antiviral pill to treat COVID-19 A new oral treatment reduces the risk of hospitalisation and death due to COVID by 50%, research suggests.
Gold standard trial finds remdesivir shortens duration of COVID-19 The results have confirmed doctors’ experiences of treating COVID patients in Australia.
GP-led research finds management of CVD ‘suboptimal’ But it highlights the need for a person-centred model of care, according to lead author Associate Professor Charlotte Hespe.
COVID-19 research receives $66 million boost The funding injection will target four areas of research in the quest for a vaccine and preparation for future pandemics.
Remdesivir and COVID-19: What GPs need to know It has become the first therapy for COVID-19 to receive FDA approval for emergency use – but evidence of its effectiveness remains mixed.